Since its launch in 2021, Profilometry-based Indentation Plastometry (PIP) testing has been widely adopted by engineers who require mechanical property data from parts that cannot be easily tested ...

Google’s newest AI model, Gemini 3 Pro, has been getting plenty of praise for its raw capability — but a recent report out of South Korea is now questioning whether its safety has kept pace. According ...

Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...

Neurogen Biomarking is expanding its home-based Alzheimer’s testing model through a partnership with Tasso, which will supply its needle-free blood collection devices for use across Neurogen’s ...

Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development. Earlier this week, the UK’s science minister announced an ambitious plan: to phase out ...

Plastometrex, a material testing company, has led the development of ASTM Standard E3499-25 for Profilometry-based Indentation Plastometry (PIP), giving engineers and researchers a globally recognized ...

President Donald Trump on Thursday vowed to begin testing US nuclear weapons “on an equal basis” with Russia and China, heralding a potentially major shift in decades of US policy at a time of growing ...

The president's announcement that the U.S. would resume tests leaves questions. President Donald Trump raised questions Wednesday night about a decades-old U.S. prohibition on testing its nuclear ...

BridgeBio has vaulted over the success bar it set for a phase 3 rare disease trial, linking the candidate to significant improvements on biomarker and clinical outcomes to tee up a filing for FDA ...

Data presented at IDWeek 2025 alongside additional clinical and validation data, education session on the use of metagenomics in central nervous system infections “Due to its ability to detect a wide ...

New Data Show Early Use of Delve Bio’s Metagenomic Testing Can Reduce Need for Conventional Tests and Overall Length of Stay for Patients with Meningitis/Encephalitis Data presented at IDWeek 2025 ...